Cognex [CGNX] vs MKS Instruments [MKSI] Detailed Stock Comparison
Cognex
NASDAQ
Loading...
MKS Instruments
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cognex wins in 8 metrics, MKS Instruments wins in 12 metrics, with 0 ties. MKS Instruments appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cognex | MKS Instruments | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.01 | 27.98 | MKS Instruments |
| Price-to-Book Ratio | 4.58 | 2.67 | MKS Instruments |
| Debt-to-Equity Ratio | 5.52 | 199.70 | Cognex |
| PEG Ratio | 42.76 | 11.97 | MKS Instruments |
| EV/EBITDA | 40.84 | 11.78 | MKS Instruments |
| Profit Margin (TTM) | 13.13% | 6.21% | Cognex |
| Operating Margin (TTM) | 17.44% | 13.78% | Cognex |
| EBITDA Margin (TTM) | 17.44% | 13.78% | Cognex |
| Return on Equity | 8.10% | 9.50% | MKS Instruments |
| Return on Assets (TTM) | 4.11% | 3.82% | Cognex |
| Free Cash Flow (TTM) | $134.04M | $410.00M | MKS Instruments |
| Dividend Yield | 0.96% | 1.23% | MKS Instruments |
| 1-Year Return | 6.76% | -17.12% | Cognex |
| Price-to-Sales Ratio (TTM) | 7.41 | 1.73 | MKS Instruments |
| Enterprise Value | $6.72B | $10.35B | MKS Instruments |
| EV/Revenue Ratio | 7.23 | 2.83 | MKS Instruments |
| Gross Profit Margin (TTM) | 67.39% | 47.44% | Cognex |
| Revenue per Share (TTM) | $5 | $54 | MKS Instruments |
| Earnings per Share (Diluted) | $0.72 | $3.36 | MKS Instruments |
| Beta (Stock Volatility) | 1.47 | 1.85 | Cognex |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cognex vs MKS Instruments Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cognex | -1.09% | 1.45% | 29.86% | 45.58% | 8.24% | 15.85% |
| MKS Instruments | 0.60% | 3.77% | -3.34% | 32.93% | -9.70% | -6.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cognex | 6.76% | -14.23% | -38.72% | 123.57% | 732.19% | 435.75% |
| MKS Instruments | -17.12% | -25.82% | -27.96% | 152.88% | 378.74% | 402.64% |
Performance & Financial Health Analysis: Cognex vs MKS Instruments
| Metric | CGNX | MKSI |
|---|---|---|
| Market Information | ||
| Market Cap | $6.89B | $6.30B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,607,209 | 1,069,570 |
| 90 Day Avg. Volume | 2,043,183 | 980,340 |
| Last Close | $40.91 | $99.36 |
| 52 Week Range | $22.67 - $44.17 | $54.84 - $125.33 |
| % from 52W High | -7.38% | -20.72% |
| All-Time High | $101.82 (Feb 08, 2021) | $199.44 (Apr 05, 2021) |
| % from All-Time High | -59.82% | -50.18% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.08% |
| Quarterly Earnings Growth | 0.12% | 2.47% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.06% |
| Operating Margin (TTM) | 0.17% | 0.14% |
| Return on Equity (TTM) | 0.08% | 0.10% |
| Debt to Equity (MRQ) | 5.52 | 199.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.97 | $35.19 |
| Cash per Share (MRQ) | $1.36 | $9.77 |
| Operating Cash Flow (TTM) | $190.80M | $602.00M |
| Levered Free Cash Flow (TTM) | $166.53M | $589.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.96% | 1.23% |
| Last 12-Month Dividend | $0.39 | $1.10 |
Valuation & Enterprise Metrics Analysis: Cognex vs MKS Instruments
| Metric | CGNX | MKSI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.01 | 27.98 |
| Forward P/E | 42.76 | 11.97 |
| PEG Ratio | 42.76 | 11.97 |
| Price to Sales (TTM) | 7.41 | 1.73 |
| Price to Book (MRQ) | 4.58 | 2.67 |
| Market Capitalization | ||
| Market Capitalization | $6.89B | $6.30B |
| Enterprise Value | $6.72B | $10.35B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.23 | 2.83 |
| Enterprise to EBITDA | 40.84 | 11.78 |
| Risk & Other Metrics | ||
| Beta | 1.47 | 1.85 |
| Book Value per Share (MRQ) | $8.97 | $35.19 |
Financial Statements Comparison: Cognex vs MKS Instruments
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CGNX | MKSI |
|---|---|---|
| Revenue/Sales | $216.04M | $936.00M |
| Cost of Goods Sold | $71.71M | $492.00M |
| Gross Profit | $144.32M | $444.00M |
| Research & Development | $34.73M | $70.00M |
| Operating Income (EBIT) | $26.09M | $129.00M |
| EBITDA | $32.49M | $224.00M |
| Pre-Tax Income | $27.80M | $59.00M |
| Income Tax | $4.20M | $7.00M |
| Net Income (Profit) | $23.60M | $52.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CGNX | MKSI |
|---|---|---|
| Cash & Equivalents | $143.74M | $655.00M |
| Total Current Assets | $577.68M | $2.43B |
| Total Current Liabilities | $183.96M | $781.00M |
| Long-Term Debt | $63.43M | $4.62B |
| Total Shareholders Equity | $1.45B | $2.35B |
| Retained Earnings | $405.95M | $512.00M |
| Property, Plant & Equipment | $166.19M | $1.01B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CGNX | MKSI |
|---|---|---|
| Operating Cash Flow | $47.37M | $90.00M |
| Capital Expenditures | $-2.50M | $-18.00M |
| Free Cash Flow | $38.00M | $123.00M |
| Debt Repayment | N/A | $-113.00M |
| Common Stock Repurchase | $-102.23M | $-45.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CGNX | MKSI |
|---|---|---|
| Shares Short | 5.74M | 3.84M |
| Short Ratio | 3.35 | 4.13 |
| Short % of Float | 0.04% | 0.07% |
| Average Daily Volume (10 Day) | 2,607,209 | 1,069,570 |
| Average Daily Volume (90 Day) | 2,043,183 | 980,340 |
| Shares Outstanding | 170.43M | 67.40M |
| Float Shares | 160.31M | 66.60M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.99% | 1.09% |
Dividend Analysis & Yield Comparison: Cognex vs MKS Instruments
| Metric | CGNX | MKSI |
|---|---|---|
| Last 12-Month Dividend | $0.39 | $1.10 |
| Last 12-Month Dividend Yield | 0.96% | 1.23% |
| 3-Year Avg Annual Dividend | $0.32 | $0.88 |
| 3-Year Avg Dividend Yield | 0.18% | 0.22% |
| 3-Year Total Dividends | $0.95 | $2.64 |
| Ex-Dividend Date | Aug 14, 2025 | Aug 25, 2025 |